FI972555A0 - Päällystettyjen tablettien valmistus - Google Patents

Päällystettyjen tablettien valmistus

Info

Publication number
FI972555A0
FI972555A0 FI972555A FI972555A FI972555A0 FI 972555 A0 FI972555 A0 FI 972555A0 FI 972555 A FI972555 A FI 972555A FI 972555 A FI972555 A FI 972555A FI 972555 A0 FI972555 A0 FI 972555A0
Authority
FI
Finland
Prior art keywords
pct
procedure
preparation
coated tablets
sec
Prior art date
Application number
FI972555A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972555A (fi
Inventor
Joerg Rosenberg
Werner Maier
Sven Grabowski
Joerg Breitenbach
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6537025&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI972555(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Basf Ag filed Critical Basf Ag
Publication of FI972555A publication Critical patent/FI972555A/fi
Publication of FI972555A0 publication Critical patent/FI972555A0/fi

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B30—PRESSES
    • B30B—PRESSES IN GENERAL
    • B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
    • B30B11/34—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses for coating articles, e.g. tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/005—Coating of tablets or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B30—PRESSES
    • B30B—PRESSES IN GENERAL
    • B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
    • B30B11/16—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using pocketed rollers, e.g. two co-operating pocketed rollers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B9/00—Enclosing successive articles, or quantities of material, e.g. liquids or semiliquids, in flat, folded, or tubular webs of flexible sheet material; Subdividing filled flexible tubes to form packages
    • B65B9/02—Enclosing successive articles, or quantities of material between opposed webs
    • B65B9/04—Enclosing successive articles, or quantities of material between opposed webs one or both webs being formed with pockets for the reception of the articles, or of the quantities of material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2200/00—General characteristics or adaptations
    • A61J2200/20—Extrusion means, e.g. for producing pharmaceutical forms
FI972555A 1994-12-23 1997-06-16 Päällystettyjen tablettien valmistus FI972555A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4446468A DE4446468A1 (de) 1994-12-23 1994-12-23 Verfahren zur Herstellung von umhüllten Tabletten
PCT/EP1995/005118 WO1996019963A1 (de) 1994-12-23 1995-12-22 Verfahren zur herstellung von umhüllten tabletten

Publications (2)

Publication Number Publication Date
FI972555A FI972555A (fi) 1997-06-16
FI972555A0 true FI972555A0 (fi) 1997-06-16

Family

ID=6537025

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972555A FI972555A0 (fi) 1994-12-23 1997-06-16 Päällystettyjen tablettien valmistus

Country Status (24)

Country Link
US (1) US5897910A (zh)
EP (1) EP0799012B1 (zh)
JP (1) JPH10511288A (zh)
CN (1) CN1113638C (zh)
AT (1) ATE190222T1 (zh)
AU (1) AU696878B2 (zh)
CZ (1) CZ185297A3 (zh)
DE (2) DE4446468A1 (zh)
DK (1) DK0799012T3 (zh)
ES (1) ES2143089T3 (zh)
FI (1) FI972555A0 (zh)
GR (1) GR3032913T3 (zh)
HU (1) HUT77458A (zh)
IL (1) IL116519A (zh)
MX (1) MX9704568A (zh)
NO (1) NO972895L (zh)
NZ (1) NZ298414A (zh)
PL (1) PL178963B1 (zh)
RU (1) RU2177310C2 (zh)
SK (1) SK77197A3 (zh)
TR (1) TR199501670A2 (zh)
TW (1) TW381020B (zh)
WO (1) WO1996019963A1 (zh)
ZA (1) ZA9510955B (zh)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19710213A1 (de) * 1997-03-12 1998-09-17 Basf Ag Verfahren zur Herstellung von festen Kombinationsarzneiformen
US20060141036A1 (en) * 1997-12-12 2006-06-29 Andrx Labs Llc HMG-CoA reductase inhibitor extended release formulation
US20040029962A1 (en) * 1997-12-12 2004-02-12 Chih-Ming Chen HMG-COA reductase inhibitor extended release formulation
TW407058B (en) * 1998-07-17 2000-10-01 Dev Center Biotechnology Oral cisapride dosage forms with an extended duration
DE19839276A1 (de) 1998-08-28 2000-03-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19840256A1 (de) * 1998-09-03 2000-03-09 Basf Ag Verfahren zur Herstellung von beschichteten festen Dosierungsformen
US6733789B1 (en) 1999-01-21 2004-05-11 Biovail Laboratories, Inc. Multiparticulate bisoprolol formulation
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
EP1175205B1 (en) * 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
GB9927682D0 (en) * 1999-11-23 2000-01-19 Unilever Plc Process for the manufacture of shaped articles
US20040185099A1 (en) * 2000-01-20 2004-09-23 Biovail Laboratories, Inc. Multiparticulate bisoprolol formulation
US6254888B1 (en) 2000-01-28 2001-07-03 Boehringer Ingelheim Pharmaceuticals, Inc. Method for coating pharmaceutical dosage forms
GB0008553D0 (en) * 2000-04-06 2000-05-24 Unilever Plc Process and apparatus for the production of a detergent bar
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US20030032675A1 (en) * 2001-02-15 2003-02-13 Franz G. Andrew Manufacture of thyroid hormone tablets having consistent active moiety amounts
KR20040100835A (ko) * 2001-02-15 2004-12-02 킹 파머슈티칼스 리서치 앤드 디벨로프먼트 아이엔씨 안정된 제약및 갑상선 내분비 호르몬 구성물 및 그제조방법
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US6767619B2 (en) * 2001-05-17 2004-07-27 Charles R. Owens Preform for manufacturing a material having a plurality of voids and method of making the same
GB0113403D0 (en) * 2001-06-02 2001-07-25 Bioprogress Tech Int Inc Tablet enrobing
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US20030198667A1 (en) * 2001-08-10 2003-10-23 Franz Andrew G. Methods of producing dispersible pharmaceutical compositions
US20030180353A1 (en) * 2001-08-10 2003-09-25 Franz G. Andrew Stabilized pharmaceutical compositions
US20030190349A1 (en) * 2001-08-10 2003-10-09 Franz G. Andrew Methods of stabilizing pharmaceutical compositions
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US20030198672A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique triidothyronine plasma AUC properties
US20030199587A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique Cmax properties
US20030195253A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US20030199586A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Unique levothyroxine aqueous materials
US20030203967A1 (en) * 2001-08-14 2003-10-30 Franz G. Andrew Levothyroxine compositions having unique Tmax properties
ATE404179T1 (de) * 2001-09-28 2008-08-15 Mcneil Ppc Inc Darreichungsformen mit kern und äusserer hülle
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7217381B2 (en) * 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US20030190350A1 (en) * 2001-10-29 2003-10-09 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
US20030091633A1 (en) * 2001-11-15 2003-05-15 John Kelly Methods and compositions for use of (S)-bisoprolol
US20030118652A1 (en) * 2001-11-15 2003-06-26 John Kelly Methods and compositions for use of (S)-bisoprolol
US9233049B2 (en) * 2002-10-31 2016-01-12 Purdue Pharma L.P. Pharmaceutical identification
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
CA2510261A1 (en) * 2002-12-17 2004-07-01 Abbott Gmbh & Co. Kg Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
US20050025825A1 (en) 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
US20090214644A1 (en) * 2003-07-31 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations with reduced adverse effects
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) * 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
CA2551528A1 (en) * 2003-12-31 2005-07-21 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
DE102004008804A1 (de) * 2004-02-20 2005-09-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Mehrschichttablette
US20050245614A1 (en) * 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20090215898A1 (en) * 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US7947739B2 (en) 2004-03-04 2011-05-24 Ferring B.V. Tranexamic acid formulations
US8022106B2 (en) * 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
US8071695B2 (en) * 2004-11-12 2011-12-06 Eastman Chemical Company Polyeste blends with improved stress whitening for film and sheet applications
EP1693045A1 (de) * 2005-02-17 2006-08-23 Abbott GmbH & Co. KG Herstellung von Dosierungsformen aus wirkstoffhaltigen Schmelzen
US20070264026A1 (en) * 2006-05-10 2007-11-15 Miguel Joseph D Method and apparatus for controlling phase of a clock signal
US20080038334A1 (en) * 2006-08-08 2008-02-14 John Zazula Method for producing and a system for cooling a hot-filled softgel capsule
WO2008067164A2 (en) * 2006-11-15 2008-06-05 Abbott Laboratories Solid pharmaceutical dosage formulations
CN101600564B (zh) * 2007-01-30 2012-06-13 新东工业株式会社 颗粒状物料的挤压成型方法及挤压成型设备
CA2684173C (en) * 2007-04-26 2015-06-30 Eisai R&D Management Co., Ltd. Process for production of tablet
FR2926724B1 (fr) * 2008-01-25 2010-06-18 Duo Ge Nouvelle forme pharmaceutique orale.
EP2249815B1 (en) * 2008-01-25 2020-06-24 Laboratoires Majorelle Combinations of oral medicaments bonded by a wrapping
FR2926723B1 (fr) * 2008-01-25 2010-06-18 Duo Ge Associations pharmaceutiques orales.
PL2410970T3 (pl) 2009-03-26 2013-07-31 Swiss Caps Rechte Und Lizenzen Ag Sposób i urządzenie do wytwarzania kapsułek miękkich
US20100280117A1 (en) * 2009-04-30 2010-11-04 Xanodyne Pharmaceuticals, Inc. Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
IN2014DN09338A (zh) * 2013-05-16 2015-07-10 Korsch Ag
WO2015003660A1 (zh) * 2013-07-11 2015-01-15 天士力制药集团股份有限公司 气冷滴丸生产线
CN104886232A (zh) * 2015-06-19 2015-09-09 湖北智联行现代农业科技有限公司 猕猴桃的存储方法及包装设备

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2513852A (en) * 1946-12-26 1950-07-04 Alfonso M Donofrio Method for encapsulating
DE1766546C3 (de) * 1968-06-11 1974-11-28 Karl Gunnar Lidingoe Eriksson Verfahren zum Herstellen von festen dragee- oder tablettenförmigen Arzneimittelzubereitungen
US4154636A (en) * 1975-08-27 1979-05-15 Freund Industrial Co., Ltd. Method of film-coating medicines
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
US4375146A (en) * 1979-06-11 1983-03-01 International Automated Machinery, Inc. Continuous rotary machine and method for forming, filling, and sealing package of laminated sheet material
FI66642C (fi) * 1982-08-20 1984-11-12 Outokumpu Oy Foerfarande foer effektivering av brikettering
DE8536337U1 (de) * 1985-12-23 1986-02-13 R.P. Scherer GmbH, 6930 Eberbach Füllkeil für eine Maschine zum Herstellen von Gelatinekapseln
DE3612211A1 (de) * 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
US5146730A (en) * 1989-09-20 1992-09-15 Banner Gelatin Products Corp. Film-enrobed unitary-core medicament and the like
US5192548A (en) * 1990-04-30 1993-03-09 Riker Laboratoires, Inc. Device

Also Published As

Publication number Publication date
FI972555A (fi) 1997-06-16
DE59507973D1 (de) 2000-04-13
IL116519A (en) 2000-07-26
SK77197A3 (en) 1998-02-04
AU4389596A (en) 1996-07-19
NO972895D0 (no) 1997-06-20
ATE190222T1 (de) 2000-03-15
AU696878B2 (en) 1998-09-17
CN1113638C (zh) 2003-07-09
DK0799012T3 (da) 2000-06-05
EP0799012B1 (de) 2000-03-08
WO1996019963A1 (de) 1996-07-04
JPH10511288A (ja) 1998-11-04
ZA9510955B (en) 1997-06-23
PL178963B1 (pl) 2000-07-31
GR3032913T3 (en) 2000-07-31
CZ185297A3 (cs) 1998-01-14
EP0799012A1 (de) 1997-10-08
TR199501670A2 (tr) 1996-07-21
PL320936A1 (en) 1997-11-10
IL116519A0 (en) 1996-03-31
HUT77458A (hu) 1998-04-28
US5897910A (en) 1999-04-27
NO972895L (no) 1997-08-05
ES2143089T3 (es) 2000-05-01
NZ298414A (en) 1999-02-25
DE4446468A1 (de) 1996-06-27
RU2177310C2 (ru) 2001-12-27
CN1171041A (zh) 1998-01-21
TW381020B (en) 2000-02-01
MX9704568A (es) 1998-07-31

Similar Documents

Publication Publication Date Title
FI972555A0 (fi) Päällystettyjen tablettien valmistus
IL117532A0 (en) Production of compositions in the form of a solid solution of an active substance in a polymer matrix
SE9404080L (sv) Förfarande för framställning av en optiskt ren enantiomer av formoterol
FI972631A0 (fi) Jaettavissa olevien tablettien valmistus
FI113644B (fi) Menetelmä terapeuttisesti aktiivisten N-substituoitujen 3- atsabisykloalkaanijohdannaisten valmistamiseksi
DE69617732T2 (de) Transdermales estradiol/progestogen-pflaster und dessen herstellung
ZA959451B (en) 2,2-Dichloroalkanecarboxylic acids process of their production and pharmaceutical agents containing these
NZ332545A (zh)
DE69606777T2 (de) Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel
AU6304796A (en) A process for the production of active substances from unused or discarded devices for the transdermal application of active substances and/or their process waste
AU4788696A (en) New derivatives of pyridine or pyridazine, process for production thereof and medicaments containing these compounds
TW374764B (en) Antitumor and antileukaemic compounds, their preparation and pharmaceutical composition containing them
AU7808394A (en) Novel dihispidine derivatives, process for producing them and medicaments containing these compounds
JO1822B1 (en) A new form of a compound
CA2208541A1 (en) The production of covered tablets
GB9320643D0 (en) Preparation of chiral compounds